108 related articles for article (PubMed ID: 27058272)
1. Evidence of contact activation in patients suffering from ST-elevation myocardial infarction.
Christensen K; Kozarcanin H; Ekdahl KN; Nilsson B
Thromb Res; 2016 May; 141():158-62. PubMed ID: 27058272
[TBL] [Abstract][Full Text] [Related]
2. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
3. Measurement of activated factor XII in health and disease.
Coppola R; Cristilli P; Cugno M; Ariëns RA; Mari D; Mannucci PM
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):530-5. PubMed ID: 8874863
[TBL] [Abstract][Full Text] [Related]
4. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces.
Bäck J; Lang MH; Elgue G; Kalbitz M; Sanchez J; Ekdahl KN; Nilsson B
Biomaterials; 2009 Dec; 30(34):6573-80. PubMed ID: 19783299
[TBL] [Abstract][Full Text] [Related]
5. Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity.
Altieri P; Devoto E; Spallarossa P; Rossettin P; Garibaldi S; Bertero G; Balbi M; Barsotti A; Brunelli C; Ghigliotti G
Thromb Res; 2005; 115(1-2):65-72. PubMed ID: 15567455
[TBL] [Abstract][Full Text] [Related]
6. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
[TBL] [Abstract][Full Text] [Related]
7. Activated human platelets induce factor XIIa-mediated contact activation.
Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal relationship between contact and complement system activation on artificial polymers exposed to whole human blood.
Huang S; Engberg AE; Jonsson N; Sandholm K; Nicholls IA; Mollnes TE; Fromell K; Nilsson B; Ekdahl KN
Biomaterials; 2016 Jan; 77():111-9. PubMed ID: 26584351
[TBL] [Abstract][Full Text] [Related]
9. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
[TBL] [Abstract][Full Text] [Related]
10. Ongoing contact activation in patients with hereditary angioedema.
Konings J; Cugno M; Suffritti C; Ten Cate H; Cicardi M; Govers-Riemslag JW
PLoS One; 2013; 8(8):e74043. PubMed ID: 24013493
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk.
Bach J; Endler G; Winkelmann BR; Boehm BO; Maerz W; Mannhalter C; Hellstern P
J Thromb Haemost; 2008 Feb; 6(2):291-6. PubMed ID: 18021303
[TBL] [Abstract][Full Text] [Related]
12. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
Sanchez J; Elgue G; Riesenfeld J; Olsson P
Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
[TBL] [Abstract][Full Text] [Related]
13. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
[TBL] [Abstract][Full Text] [Related]
15. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction.
Grundt H; Nilsen DW; Hetland Ø; Valente E; Fagertun HE
Am Heart J; 2004 Feb; 147(2):260-6. PubMed ID: 14760323
[TBL] [Abstract][Full Text] [Related]
16. Role of contact system activation in hemodialyzer-induced thrombogenicity.
Frank RD; Weber J; Dresbach H; Thelen H; Weiss C; Floege J
Kidney Int; 2001 Nov; 60(5):1972-81. PubMed ID: 11703617
[TBL] [Abstract][Full Text] [Related]
17. Competitive-protein adsorption in contact activation of blood factor XII.
Zhuo R; Siedlecki CA; Vogler EA
Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
[TBL] [Abstract][Full Text] [Related]
18. Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
Kohler HP; Carter AM; Stickland MH; Grant PJ
Thromb Haemost; 1998 Jan; 79(1):14-8. PubMed ID: 9459314
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia.
Cardigan RA; Crook M; Mackie IJ; Machin SJ
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):187-92. PubMed ID: 11414632
[TBL] [Abstract][Full Text] [Related]
20. Single-chain factor XII: a new form of activated factor XII.
Ivanov I; Matafonov A; Gailani D
Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
